Cardiologists claim success with growth factor therapy
This article was originally published in Clinica
Growth factor therapy sustained over time appears to be an effective way to revascularise the heart and could be an alternative to bypass surgery, and even newer techniques such as laser revascularisation (TMR), in patients with severe angina. In addition, the treatment appears safe and free of side-effects, according to a double blind, randomised, controlled study reported in the November 2 edition of Circulation.
You may also be interested in...
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.
Rosa DeLauro prevails over fellow Democrats Debbie Wasserman Schultz and Marcy Kaptur for Appropriations chair. Frank Pallone gets unanimous support from Democrats to continue as Energy and Commerce chair.